This is a preview of subscription content, log in via an institution to check access.
References
Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156–1161.
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524–15529.
Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008; 205: 2499–2506.
Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009; 23: 862–876.
Sonoki T, Iwanaga E, Mitsuya H, Asou N . Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 2005; 19: 2009–2010.
Tassano EAM, Acquila M, Tavella E, Rosanda C, Micalizzi C, Panarello C et al. A novel chromosomal translocation t(11;14)(q24.1;q32) involving IGH in childhood B-cell precursor acute lymphoblastic leukaemia. Haematologica 2009; 94 (s2): 0063a.
Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia 2010; 24: 89–96.
Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA 2007; 104: 19983–19988.
Acknowledgements
We thank F Davi, C Gervais and C Henry for their valuable help, Fiona Ross, Wessex Regional Genetics Laboratory, Salisbury, UK for providing material, and Leukaemia and Lymphoma Research for financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Chapiro, E., Russell, L., Struski, S. et al. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia 24, 1362–1364 (2010). https://doi.org/10.1038/leu.2010.93
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.93
- Springer Nature Limited
This article is cited by
-
Understanding of leukemic stem cells and their clinical implications
Molecular Cancer (2017)
-
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment
British Journal of Cancer (2017)
-
MicroRNAs as prognostic biomarker and relapse indicator in leukemia
Clinical and Translational Oncology (2017)
-
MAP3K11 is a tumor suppressor targeted by the oncomiR miR-125b in early B cells
Cell Death & Differentiation (2016)
-
Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease
Scientific Reports (2015)